Fermented Cholesterol Lowering Drug (Lovastatin) Sadia Javed, Munazzah Meraj and SHAZIA ANWER BUKHARI

Lovastatin is an inhibitor of 3-hydroxy-3methylglutaryl-coenzyme A reductase (HMG-CoA reductase), an enzyme that catalyzes the conversion of HMG-CoA to mevalonate. In western countries, the most significant cause of death is the coronary heart disease and progression of atherosclerosis which is mostly related to the hypercholesterolemia. Approximately 10.8% of all deaths are caused due to this disease. Coronary heart disease actually is a wide assortment of diseases. It has been reported that 30 million people have familial hypercholesterolemia worldwide, but less than 1% of cases are diagnosed in most countries. A lab experiment was carried out for fungal production of lovastatin in solid state fermentation. Fermentation medium was optimized by optimizing the fermentation parameters (pH, temperature, inoculum size, moisture contents etc.). Это и многое другое вы найдете в книге Fermented Cholesterol Lowering Drug (Lovastatin) (Sadia Javed,Munazzah Meraj and Shazia Anwer Bukhari)